METHODS	Multiparameter flow cytometry ( MFC ) was used to assess MRD after induction therapy ( n = 378 ) and at day 100 after autologous stem-cell transplantation ( ASCT ; n = 397 ) in intensive-pathway patients and at the end of induction therapy in non-intensive-pathway patients ( n = 245 ) .\